ASSOCIAZIONI 4 AUGUST 2020 Omisan Farmaceutici enters the Corporate Advisory Board of TFOS. Omisan Farmaceutici, an Italian company that for over 20 years has been manufacturing sterile medical equipment for the care of eyes and contact lenses, is part of the Corporate Advisory Board of the prestigious Tear Film & Ocular Surface Society (TFOS) of Boston. An international non-profit society of reference in this field, TFOS promotes research, expertise and the educational aspects of this particular scientific sector. The choice emphasises Omisan Farmaceutici’s focus on dry eye and specific products for treating the symptoms of dryness. The Italian company will be represented by its founder, Dr Nevio Vona. Sharing Twitter0 Facebook0 Google +0 Linkedinactive){li-icon[type=linkedin-bug][color=inverse] .background{fill Email this article Print this article Tags Nevio Vona, omisan, optosan, corporate advisory board, tfos, MIDO, WMIDO
ACCORDI/LICENZE 11 JANUARY 2021 Fielmann AG acquires an 80 percent equity ownership stake in Óptica & Audiología Universitaria.
ACCORDI/LICENZE 29 DECEMBER 2020 La Martina awards Jet Set Group the licence for its new line of eyewear.
ACCORDI/LICENZE 7 DECEMBER 2020 Starting January 1, 2021 Neubau Eyewear will begin operating as an independent entity of Silhouette International